Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry in Hungary

The country was number 12 in 2023, the United Kingdom overtook $591,540,000 Million PPP. China, Germany and Belgium respectively came in numbers 2, 3 and 4 in this ranking.

How does Hungary rank in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry?

# 25 Countries Million US Dollars PPP, Constant Last Year YoY 5-years CAGR
1 1 United States 93,883,000,000 2023 +3.28% +5.52% View data
2 2 China 25,800,000,000 2023 +10.43% +13.47% View data
3 3 Germany 6,446,800,000 2023 +1.23% +0.14% View data
4 4 Belgium 3,844,700,000 2023 +3.57% +4.12% View data
5 5 South Korea 2,938,200,000 2023 +6.78% +10.81% View data
10 10 Taiwan 605,250,000 2023 +3.34% +3.83% View data
11 11 United Kingdom 600,300,000 2023 -0.52% -0.33% View data
12 12 Hungary 591,540,000 2023 +1.64% +2.35%
13 13 Ireland 413,360,000 2023 +2.15% +2.33% View data
14 14 Austria 351,950,000 2023 +0.44% -0.66% View data

Latest reports

 US Pharmaceuticals Market Report- Q4 2024

US Pharmaceuticals Market Report- Q4 2024

In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...

 Japan Pharmaceuticals Market Report- Q4 2024

Japan Pharmaceuticals Market Report- Q4 2024

The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...

 Germany Pharmaceuticals Market Report- Q4 2024

Germany Pharmaceuticals Market Report- Q4 2024

The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...

 India Pharmaceuticals Market Report- Q4 2024

India Pharmaceuticals Market Report- Q4 2024

The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...

 UK Pharmaceuticals Market Report- Q4 2024

UK Pharmaceuticals Market Report- Q4 2024

The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...

 France Pharmaceuticals Market Report- Q4 2024

France Pharmaceuticals Market Report- Q4 2024

The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...

 Canada Pharmaceuticals Market Report- Q4 2024

Canada Pharmaceuticals Market Report- Q4 2024

In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...

 Brazil Pharmaceuticals Market Report- Q4 2024

Brazil Pharmaceuticals Market Report- Q4 2024

The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...

 Italy Pharmaceuticals Market Report- Q4 2024

Italy Pharmaceuticals Market Report- Q4 2024

The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...

 South Korea Pharmaceuticals Market Report- Q1 2025

South Korea Pharmaceuticals Market Report- Q1 2025

The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...

Top Countries about Pharmaceutical